A new biomarker of breast cancer stage and patient response to neoadjuvant chemotherapy: HLA-DR expression in cytotoxic and regulatory T cells

Research output: Contribution to journalMeeting Abstract

Original languageEnglish
JournalAnnals Of Oncology
Volume29
Publication statusPublished - Oct 2018

Cite this